Morgan Stanley Maintains Overweight on American Healthcares, Raises Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ronald Kamdem has maintained an Overweight rating on American Healthcares (NYSE:AHR) and raised the price target from $17 to $22.
August 22, 2024 | 12:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has increased its price target for American Healthcares from $17 to $22, maintaining an Overweight rating. This suggests a positive outlook for the stock.
The increase in price target from $17 to $22 by Morgan Stanley indicates a strong positive sentiment towards American Healthcares. The Overweight rating suggests that the stock is expected to outperform, which is likely to have a positive impact on its short-term price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100